$GTCH big news for the company: GEN II Prototype q
Post# of 40420
(Total Views: 141)
Posted On: 06/01/2021 2:13:08 PM
$GTCH big news for the company: GEN II Prototype qTerm Includes a Series of Enhancements
SAN DIEGO, May 26, 2021 (GLOBE NEWSWIRE) -- GBT Technologies Inc. (OTC PINK: GTCH) ("GBT”, or the “Company”) via GBT Tokenize Corp, completed generation II of its qTerm device. The GEN II release is a second version that includes a series of enhancements that target higher measurement accuracy, reliability and compatibility with a broader spectrum of users usage behavior. GBT's qTerm, a human vitals intelligent device is aimed to measure human vitals with a touch of a finger. Based on GEN I prototype testing, debugging and study, GBT’s concluded GEN II version to significantly advance the device’s general population compatibility. qTerm’s second release includes body temperature, blood oxygen and heart rate vitals with higher stability, and consistency to cover wider spectrum of users measurement habits. The device’s sensors were physically re-located to more efficient positions to enable best and consistent results. An additional coprocessor chip was installed to provide an advanced adjusting algorithm to support broader user’s measuring habits, compensating for different inputs and providing consistent results. Similar to the GEN I version, the GEN II device will be accompanied by a smartphone app and synchronized web application to keep a history and provide analytics for user's records at a later phase.
SAN DIEGO, May 26, 2021 (GLOBE NEWSWIRE) -- GBT Technologies Inc. (OTC PINK: GTCH) ("GBT”, or the “Company”) via GBT Tokenize Corp, completed generation II of its qTerm device. The GEN II release is a second version that includes a series of enhancements that target higher measurement accuracy, reliability and compatibility with a broader spectrum of users usage behavior. GBT's qTerm, a human vitals intelligent device is aimed to measure human vitals with a touch of a finger. Based on GEN I prototype testing, debugging and study, GBT’s concluded GEN II version to significantly advance the device’s general population compatibility. qTerm’s second release includes body temperature, blood oxygen and heart rate vitals with higher stability, and consistency to cover wider spectrum of users measurement habits. The device’s sensors were physically re-located to more efficient positions to enable best and consistent results. An additional coprocessor chip was installed to provide an advanced adjusting algorithm to support broader user’s measuring habits, compensating for different inputs and providing consistent results. Similar to the GEN I version, the GEN II device will be accompanied by a smartphone app and synchronized web application to keep a history and provide analytics for user's records at a later phase.
(0)
(0)